The next topic to research will be the BDNF/CREB and PI3K/AKT modulation effects of PF’s protection against Parkinson’s disease, and, in particular, the determination of the expression levels of proteins such as AKT, P-PI3K, and AKT2. Here, AKT1 is linked to Parkinson disease.